DocumentCode
2780510
Title
Active roles of glial cells in neurodegenrative disease
Author
Yamanaka, Koji
Author_Institution
Lab. for Motor Neuron Disease, RIKEN Brain Sci. Inst., Wako, Japan
fYear
2010
fDate
16-18 Dec. 2010
Firstpage
24
Lastpage
25
Abstract
Dominant mutations in the Cu/Zn superoxide dismutase (SOD1) gene lead to a familial form of amyotrophic lateral sclerosis (ALS). Although ubiquitous expression of mutant SOD1 provokes progressive, selective motor neuron degeneration in human and rodents due to an acquired toxic property (ies) of the mutant, the distinct roles of mutant toxicity within motor neurons and non-neuronal cells are recently established by our cell-type specific gene ablation from mutant SOD1 mice. The toxicity(ies) within astrocytes and microglia accelerates disease progression, indicating that glial cells contribute to non-cell autonomous neurodegeneration. Misregulated genes within glial cells that we isolated from symptomatic mutant SOD1 mice indicated the involvement of innate immune system. The inhibition of innate immune pathway in SOD1 mice significantly accelerated disease progression. These results indicate the active role of glial cells in modifying disease progression in ALS models.
Keywords
cellular biophysics; diseases; genetics; neurophysiology; toxicology; Cu/Zn superoxide dismutase mutation; SOD1 gene; amyotrophic lateral sclerosis; astrocyte; disease progression; gene ablation; glial cell; human; microglia; mutant toxicity; neurodegenrative disease; rodent; selective motor neuron degeneration; SOD1 (superoxide dismutase 1); amyotrphic lateral sclerosis; astrocyte; microglia; neurodengeration;
fLanguage
English
Publisher
ieee
Conference_Titel
Systems in Medicine and Biology (ICSMB), 2010 International Conference on
Conference_Location
Kharagpur
Print_ISBN
978-1-61284-039-0
Type
conf
DOI
10.1109/ICSMB.2010.5735340
Filename
5735340
Link To Document